Try our corporate solution for free!
+1 (212) 419-5770
esther.shaulova@statista.com

Public drug program spending in Canada by therapy share 2018

This statistic shows the proportion of the total public drug program expenditures in Canada by broad therapeutic category in 2018. In that year, over 21 percent of total drug program spending was dedicated to antineoplastic and immunomodulating agents.

Distribution of total public drug program spending in Canada by therapy in 2018*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

December 2019

Region

Canada

Survey time period

2018

Supplementary notes

* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** This category includes products without an assigned Anatomical Therapeutic Chemical (ATC) code.
*** Non-drug products include, but are not limited to, diabetic supplies, wound care, ostomy supplies and pharmaceutical services.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "Canadian pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.